» Articles » PMID: 15068488

The Osteoporosis Care Gap in Canada

Overview
Publisher Biomed Central
Specialties Orthopedics
Physiology
Date 2004 Apr 8
PMID 15068488
Citations 69
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The presence of a fragility fracture is a major risk factor for osteoporosis, and should be an indicator for osteoporosis diagnosis and therapy. However, the extent to which patients who fracture are assessed and treated for osteoporosis is not clear.

Methods: We performed a review of the literature to identify the practice patterns in the diagnosis and treatment of osteoporosis in adults over the age of 40 who experience a fragility fracture in Canada. Searches were performed in MEDLINE (1966 to January 2, 2003) and CINAHL (1982 to February 1, 2003) databases.

Results: There is evidence of a care gap between the occurrence of a fragility fracture and the diagnosis and treatment of osteoporosis in Canada. The proportion of individuals with a fragility fracture who received an osteoporosis diagnostic test or physician diagnosis ranged from 1.7% to 50%. Therapies such as hormone replacement therapy, bisphosphonates or calcitonin were being prescribed to 5.2% to 37.5% of patients. Calcium and vitamin D supplement intake was variable, and ranged between 2.8% to 61.6% of patients.

Conclusion: Many Canadians who experience fragility fracture are not receiving osteoporosis management for the prevention of future fractures.

Citing Articles

Factors Associated With Nonattendance for Osteoporosis Evaluation Following Fragility Fracture.

Seyok T, Collins J, Hodys C, Erikson S, Perez Menendez S, Earp B J Osteoporos. 2024; 2024:5602020.

PMID: 39650280 PMC: 11625084. DOI: 10.1155/joos/5602020.


Exploring barriers and opportunities to improve osteoporosis care across the acute-to-primary care interface: a qualitative study.

Bennett M, Center J, Perry L Osteoporos Int. 2023; 34(7):1249-1262.

PMID: 37093239 PMC: 10281902. DOI: 10.1007/s00198-023-06748-0.


Treatment rates and healthcare costs of patients with fragility fracture by site of care: a real-world data analysis.

Singer A, McClung M, Tran O, Morrow C, Goldstein S, Kagan R Arch Osteoporos. 2023; 18(1):42.

PMID: 36905559 PMC: 10008255. DOI: 10.1007/s11657-023-01229-7.


The association between multimorbidity and osteoporosis investigation and treatment in high-risk fracture patients in Australia: A prospective cohort study.

Bliuc D, Tran T, Chen W, Alarkawi D, Alajlouni D, Blyth F PLoS Med. 2023; 20(1):e1004142.

PMID: 36649234 PMC: 9844893. DOI: 10.1371/journal.pmed.1004142.


Hip fracture predicts subsequent hip fracture: a retrospective observational study to support a call to early hip fracture prevention efforts in post-fracture patients.

Schemitsch E, Adachi J, Brown J, Tarride J, Burke N, Oliveira T Osteoporos Int. 2021; 33(1):113-122.

PMID: 34379148 PMC: 8354846. DOI: 10.1007/s00198-021-06080-5.


References
1.
Ridout R, Hawker G . Use of bone densitometry by Ontario family physicians. Osteoporos Int. 2000; 11(5):393-9. DOI: 10.1007/s001980070105. View

2.
Davis J, Grove J, Wasnich R, Ross P . Spatial relationships between prevalent and incident spine fractures. Bone. 1999; 24(3):261-4. DOI: 10.1016/s8756-3282(98)00176-8. View

3.
Hajcsar E, Hawker G, Bogoch E . Investigation and treatment of osteoporosis in patients with fragility fractures. CMAJ. 2000; 163(7):819-22. PMC: 80503. View

4.
Fitt N, Mitchell S, Cranney A, Gulenchyn K, Huang M, Tugwell P . Influence of bone densitometry results on the treatment of osteoporosis. CMAJ. 2001; 164(6):777-81. PMC: 80872. View

5.
Khan S, de Geus C, Holroyd B, Russell A . Osteoporosis follow-up after wrist fractures following minor trauma. Arch Intern Med. 2001; 161(10):1309-12. DOI: 10.1001/archinte.161.10.1309. View